Browsing by Subject "Pentavalent antimony"

An alternative antimonial schedule to be used in cutaneous leishmaniasis when high doses of antimony are undesirable

Oliveira Neto, M. P. et al. | Date Issued: 2006

Apesar de utilizado há mais de meio século no tratamento da leishmaniose, o antimônio apresenta ainda problemas quanto a sua toxicidade e dose ideal. Doses baixas têm se mostrado tão eficazes quanto doses altas. Neste ...

A double-bind and randomized trial to evaluate Miltefosine and topical GM-CSF in the treatment of cutaneous leishmaniasis caused by Leishmania braziliensis in Brazil

Machado, Paulo Roberto Lima et al. | Date Issued: 2020

A double-bind and randomized trial to evaluate Miltefosine and topical GM-CSF in the treatment of cutaneous leishmaniasis caused by Leishmania braziliensis in Brazil (Preprint)

Machado, Paulo Roberto Lima et al. | Date Issued: 2020

Fluconazole in the Treatment of Cutaneous Leishmaniasis Caused by Leishmania braziliensis: A Randomized Controlled Trial

Prates, Fernanda Ventim de Oliveira et al. | Date Issued: 2017

Future prospects in the treatment of cutaneous leishmaniasis form: is there a place for immunomodulators in the treatment of CL?

Machado, Paulo R. L. et al. | Date Issued: 2022

Pentavalent antimony associated with G-CSF in the treatment of cutaneous leishmaniasis caused by Leishmania (Viannia) Braziliensis

Suprien, Carvel et al. | Date Issued: 2022